Pharmacokinetics of fluphenazine, a highly lipophilic drug, estimated from a pulse dose of a stable isotopomer in dogs at steady state

Journal of Pharmaceutical Sciences

Volumn 88, Issue 9, 1999, Pages 918-921

  Hubbard, John W ^a   Hadad, Salim ^a   Luo, Jiang Ping ^a   Mckay, Gordon ^a   Midha, Kamal K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DISTRIBUTION VOLUME; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG STRUCTURE; FEMALE; LIPOPHILICITY; NONHUMAN; PULSATILE DRUG RELEASE;

EID: 0032820004     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980440c     Document Type: Article

References (13)

1. Tupin, J. Focal neuroleptization: An approach to optimal dosing for initial and continuing therapy. J. Clin. Psychopharmacol. 1985, 5, 15S-21S.
2. Dysken, M. W.; Javaid, J. I.; Chang, S. S.; Schaffer, C.; Shahid, A.; Davis, J. M. Fluphenazine Pharmacokinetics and Therapeutic Response. Psychopharmacology 1981, 73, 205-210.
3. Van Putten, T.; Marder, S. R.; Wirshing, W. C.; Aravagiri, M.; Chabert, N. Neuroleptic plasma levels. Schizophr. Bull. 1991, 17, 197-216.
4. Van Putten, T.; Aravagiri, M.; Marder, S. R.; Wirshing, W. C.; Mintz, J.; Chabert, N. Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients. Psychopharmacol. Bull. 1991, 27, 91-96.
5. Midha, K. K.; Hubbard, J. W.; Marder, S. R.; Marshall, B. D.; Van Putten, T. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. J. Psychiatr. Neurosci. 1994, 19, 254-264.
6. Eichelbaum, M.; von Unruh, G.; Somogyi, A. Application of stable labeled drugs in clinical pharmacokinetic investigations. Clin. Pharmacokinet. 1982, 7, 490-507.
7. Luo, J.-P.; Hubbard, J.; Midha, K. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil. Pharmaceut. Res. 1997, 14, 1079-1084.
8. Sardessai, M. S.; Brander, M. J.; Midha, K. K.; Hawes, E. M. Synthesis of deuterium labeled fluphenazine utilizing borane reduction. J. Labelled Compd. Radiopharm. 1986, 23, 317-327.
9. Hadad, S.; Hubbard, J. W.; McKay, G.; Hawes, E. M.; Shrikhande, S.; Midha, K. K. Evidence for the lack of a human metabolic isotope effect of a deuterium analogue of fluphenazine. Pharmaceu. Res. 1995, 12, 1388-1390.
10. Edom, R.; McKay, G.; Hawes, E.; Midha, K. In Proceedings of the 37th ASMS Conference on Mass Spectrometry and Alled Topics; Miami Beach, Florida, 1989; pp 684-685.
11. Hadad, S.; Edom, R; McKay, G.; Hawes, E. M.; Midha, K. K. Simultaneous measurement of fluphenazine and [H-2(4)]-fluphenazine in plasma using solids probe tandem mass spectrometry. J. Mass Spectrom. 1995, 30, 849-856.
12. Rowland, M.; Tozer, T. Clin. Pharmacokinet. Concepts Applications, 2nd ed.; Lea & Febiger: Philadelphia and London, 1989.
13. Midha, K. K.; Hawes, E. M.; Hubbard, J. W.; Korchinski, E. D.; McKay, G. Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients. Psychopharmacology 1988, 96, 206-211.